デフォルト表紙
市場調査レポート
商品コード
1469107

バイオ医薬品産業向けオートメーション市場:2024-2034年

Automation in Biopharma Industry Market Report 2024-2034

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 364 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=204.62円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

バイオ医薬品産業向けオートメーション市場:2024-2034年
出版日: 2024年04月17日
発行: Visiongain Reports Ltd.
ページ情報: 英文 364 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオ医薬品産業向けオートメーションの市場規模は、2034年にかけてCAGR 7%で成長すると予測されています。

機械の柔軟性の向上と労働力の不足が業界の成長を促進:

製薬企業は、自動化ソリューションをより頻繁に使用したいという意向を示しており、75%がそのように回答しています。この主な原因は、労働力不足に加え、注射剤やより特殊な医薬品へのシフトです。例えば、注射剤の市場は約100%拡大し、非経口容器は2027年までCAGR 5.2%で成長すると予想されています。医薬品製造システムは、プレフィルドシリンジやオーダーメイド投与などのハードルに直面しています。そのため、少量のバッチサイズで多様なフォーマットに対応するため、製造業者はダウンタイムを抑制できるギアを探しています。

製造各社は、労働者の不足に直面しており、状況は過去2年間で大幅に悪化しました。2022年、PMMI (Packaging and Processing Technologies Association) はホワイトペーパーを発表し、その中で製薬企業の33%が人員確保に問題を抱えていると述べています。オートメーション技術とロボティクスは、製薬会社の労働問題を解消できる可能性があります。

当レポートでは、世界のバイオ医薬品産業向けオートメーションの市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 産業構造

    • 最先端の技術
    • オートメーションによる製造
    • 医薬品製造におけるデジタルツイン
    • プロセスモデリング
    • 高度なプロセス制御
    • バイオ医薬品における規制の動向
  • バイオ医薬品のインダストリー4.0におけるオートメーション:概要
    • バイオ医薬品におけるオートメーションの種類とレベル
    • バイオ医薬品、デジタルアプリケーション、インダストリー4.0
    • 製造とサプライチェーン
    • 最近の動向

第4章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場牽引要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • SWOT分析
  • PESTLE分析
  • 製薬業界におけるオートメーションの重要性

第5章 バイオ医薬品産業向けオートメーション市場の分析:技術別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • オートメーション技術
  • デジタル化技術
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 バイオ医薬品産業向けオートメーション市場の分析:オートメーション技術別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 監視制御およびデータ収集 (SCADA)
  • 分散制御システム (DCS)
  • プログラマブルロジックコントローラ (PLC)
  • 製造実行システム (MES)
  • ヒューマンマシンインターフェース (HMI)
  • 高度プロセス制御 (APC)
  • エンタープライズリソースプランニング (ERP)
  • 検査情報管理システム (LIMS)
  • 顧客関係管理 (CRM)
  • 是正措置および予防措置 (CAPA)
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第7章 バイオ医薬品産業向けオートメーション市場の分析:デジタル化技術別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • IoT
  • AI
  • デジタルツイン技術
  • 拡張現実 (AR)・仮想現実 (VR)
  • 予測分析
  • クラウドコンピューティング
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第8章 バイオ医薬品産業向けオートメーション市場の分析:用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 臨床段階
  • 創薬段階
  • 生産段階
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第9章 バイオ医薬品産業向けオートメーション市場の分析:コンポーネント別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • オートメーションハードウェア
  • オートメーシションソフトウェア
  • サービスプロジェクトフェーズ
  • サービス運用フェーズ
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第10章 バイオ医薬品産業向けオートメーション市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第11章 北米のバイオ医薬品産業向けオートメーション市場の分析

第12章 欧州のバイオ医薬品産業向けオートメーション市場の分析

第13章 アジア太平洋のバイオ医薬品産業向けオートメーション市場の分析

第14章 ラテンアメリカのバイオ医薬品産業向けオートメーション市場の分析

第15章 中東・アフリカのバイオ医薬品産業向けオートメーション市場の分析

第16章 企業プロファイル

  • 競合情勢
  • Revvity Inc.
  • Siemens Healthineers AG
  • ABB
  • Rockwell Automation
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • RheoSense Inc.
  • Emerson Electric Co.
  • TetraScience, Inc.
  • ADLINK Technology Inc.
  • Acieta
  • AMETEK, Inc.
  • Baumuller

第17章 総論・提言

  • Visiongainによる総論
  • 推奨事項
図表

List of Tables

  • Table 1 Automation in Biopharma Industry Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Automation in Biopharma Industry Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Automation in Biopharma Industry Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Automation in Biopharma Industry Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Automation in Biopharma Industry Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Automation in Biopharma Industry Market Forecast by Technology 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 7 Automation Technology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 Digitization Technology Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 Automation in Biopharma Industry Market by Automation Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 Supervisory Control and Data Acquisition (SCADA) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Distributed Control Systems (DCS) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Programmable Logic Controllers (PLC) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Manufacturing Execution System (MES)Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Human-machine Interface (HMI) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Advanced Process Control (APC)Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Enterprise Resource Planning (ERP)Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Laboratory Information Management System (LIMS)Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Customer Relationship Management (CRM)Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Corrective and Preventive Actions (CAPA)Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Other Automation Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Internet of things (IoT) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Artificial Intelligence (AI) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Digital Twin Technology Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 Augmented Reality (AR) and Virtual Reality (VR) Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 26 Predictive Analytics Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 Cloud Computing Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 Automation in Biopharma Industry Market by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 Clinical Phase Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 30 Drug Discovery Phase Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 Production Phase Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 Automation Hardware Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 Automation Software Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 Services Project Phase Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 Services Operation Phase Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 Automation in Biopharma Industry Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 North America Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 North America Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 North America Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 North America Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 North America Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 North America Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 U.S. Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 Canada Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 Europe Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 47 Europe Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Europe Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Europe Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 Europe Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 Europe Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Germany Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 UK Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 France Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Italy Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 Spain Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Switzerland Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Netherlands Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Rest of Europe Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Asia Pacific Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 Asia Pacific Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Asia Pacific Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 Asia Pacific Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 Asia Pacific Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Asia Pacific Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 66 Japan Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 China Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 India Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 Australia Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 South Korea Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 South East Asia Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 Rest of Asia Pacific Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 73 Latin America Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 Latin America Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 75 Latin America Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 76 Latin America Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 77 Latin America Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 78 Latin America Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 79 Brazil Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 80 Mexico Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 81 Argentina Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 82 Rest of Latin America Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 83 MEA Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 84 MEA Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 85 MEA Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 86 MEA Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 87 MEA Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 88 MEA Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 89 GCC Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 90 South Africa Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 91 Egypt Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 92 Rest of MEA Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 93 Automation in Biopharma Industry Market: Company Ranking, 2023
  • Table 94 Revvity Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Revvity Inc.: Product Benchmarking
  • Table 96 Revvity Inc.: Strategic Outlook
  • Table 97 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Siemens Healthineers AG: Product Benchmarking
  • Table 99 Siemens Healthineers AG: Strategic Outlook
  • Table 100 ABB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 ABB: Product Benchmarking
  • Table 102 ABB: Strategic Outlook
  • Table 103 Rockwell Automation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Rockwell Automation: Product Benchmarking
  • Table 105 Rockwell Automation: Strategic Outlook
  • Table 106 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 108 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 109 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Sartorius AG: Product Benchmarking
  • Table 111 Sartorius AG: Strategic Outlook
  • Table 112 RheoSense Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 RheoSense Inc.: Product Benchmarking
  • Table 114 RheoSense Inc.: Strategic Outlook
  • Table 115 Emerson Electric Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Emerson Electric Co.: Product Benchmarking
  • Table 117 Emerson Electric Co.: Strategic Outlook
  • Table 118 TetraScience, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 TetraScience, Inc.: Product Benchmarking
  • Table 120 TetraScience, Inc.: Strategic Outlook
  • Table 121 ADLINK Technology Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 ADLINK Technology Inc.: Product Benchmarking
  • Table 123 ADLINK Technology Inc.: Strategic Outlook
  • Table 124 Acieta: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 Acieta: Product Benchmarking
  • Table 126 Acieta: Strategic Outlook
  • Table 127 AMETEK, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 AMETEK, Inc.: Product Benchmarking
  • Table 129 AMETEK, Inc.: Strategic Outlook
  • Table 130 Baumuller: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 Baumuller: Product Benchmarking
  • Table 132 Baumuller: Strategic Outlook

List of Figures

  • Figure 1 Automation in Biopharma Industry Market Segmentation
  • Figure 2 Automation in Biopharma Industry Market Attractiveness Index by Region
  • Figure 3 Automation in Biopharma Industry Market by Technology: Market Attractiveness Index
  • Figure 4 Automation in Biopharma Industry Market by Automation Technology: Market Attractiveness Index
  • Figure 5 Automation in Biopharma Industry Market by Digitization Technology: Market Attractiveness Index
  • Figure 6 Automation in Biopharma Industry Market by Application: Market Attractiveness Index
  • Figure 7 Automation in Biopharma Industry Market by Component: Market Attractiveness Index
  • Figure 8 Automation in Biopharma Industry Market: Market Dynamics
  • Figure 9 Automation in Biopharma Industry Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 10 Automation in Biopharma Industry Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 11 Automation in Biopharma Industry Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 12 Automation in Biopharma Industry Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 13 Automation in Biopharma Industry Market: Porter's Five Forces Analysis
  • Figure 14 Automation in Biopharma Industry Market: SWOT Analysis
  • Figure 15 Automation in Biopharma Industry Market: PEST Analysis
  • Figure 16 Automation in Biopharma Industry Market by Technology: Market Attractiveness Index
  • Figure 17 Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 18 Automation in Biopharma Industry Market Share Forecast by Technology, 2024, 2029, 2034 (%)
  • Figure 19 Automation Technology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 20 Automation Technology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Digitization Technology Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 22 Digitization Technology Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Automation in Biopharma Industry Market by Automation Technology: Market Attractiveness Index
  • Figure 24 Automation in Biopharma Industry Market by Type, 2024-2034 (US$ Million)
  • Figure 25 Automation in Biopharma Industry Market Share Forecast by Automation Technology, 2024, 2029, 2034 (%)
  • Figure 26 Supervisory Control and Data Acquisition (SCADA) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 27 Supervisory Control and Data Acquisition (SCADA) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 28 Distributed Control Systems (DCS) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 29 Distributed Control Systems (DCS) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 Programmable Logic Controllers (PLC) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 31 Programmable Logic Controllers (PLC) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 Manufacturing Execution System (MES)Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 33 Manufacturing Execution System (MES)Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Human-machine Interface (HMI) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 35 Human-machine Interface (HMI) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Advanced Process Control (APC)Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 37 Advanced Process Control (APC)Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Enterprise Resource Planning (ERP)Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 39 Enterprise Resource Planning (ERP)Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 40 Laboratory Information Management System (LIMS)Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 41 Laboratory Information Management System (LIMS)Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 42 Customer Relationship Management (CRM)Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 43 Customer Relationship Management (CRM)Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 44 Corrective and Preventive Actions (CAPA)Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 45 Corrective and Preventive Actions (CAPA)Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 46 Other Automation Technologies Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 47 Other Automation Technologies Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 48 Automation in Biopharma Industry Market by Digitization Technology: Market Attractiveness Index
  • Figure 49 Automation in Biopharma Industry Market Forecast by Type, 2024-2034 (US$ Million)
  • Figure 50 Automation in Biopharma Industry Market Share Forecast by Type, 2024, 2029, 2034 (%)
  • Figure 51 Internet of things (IoT) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 52 Internet of things (IoT) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 53 Artificial Intelligence (AI) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 54 Artificial Intelligence (AI) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 55 Digital Twin Technology Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 56 Digital Twin Technology Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 57 Augmented Reality (AR) and Virtual Reality (VR) Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 58 Augmented Reality (AR) and Virtual Reality (VR) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 59 Predictive Analytics Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 60 Predictive Analytics Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 61 Cloud Computing Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 62 Cloud Computing Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 63 Automation in Biopharma Industry Market by Application: Market Attractiveness Index
  • Figure 64 Automation in Biopharma Industry Market by Application, 2024-2034 (US$ Million)
  • Figure 65 Automation in Biopharma Industry Market Share by Application, 2024, 2029, 2034 (%)
  • Figure 66 Clinical Phase Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 67 Clinical Phase Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 68 Drug Discovery Phase Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 69 Drug Discovery Phase Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 70 Production Phase Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 71 Production Phase Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 72 Automation in Biopharma Industry Market by Component: Market Attractiveness Index
  • Figure 73 Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million)
  • Figure 74 Automation in Biopharma Industry Market Share Forecast by Component, 2024, 2029, 2034 (%)
  • Figure 75 Automation Hardware Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 76 Automation Hardware Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 77 Automation Software Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 78 Automation Software Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 79 Services Project Phase Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 80 Services Project Phase Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 81 Services Operation Phase Market Forecast by Region, 2024-2034 (US$ Million)
  • Figure 82 Services Operation Phase Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 83 Automation in Biopharma Industry Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
  • Figure 84 Automation in Biopharma Industry Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 85 Automation in Biopharma Industry Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 86 North America Automation in Biopharma Industry Market Attractiveness Index
  • Figure 87 North America Automation in Biopharma Industry Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 88 North America Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 89 North America Automation in Biopharma Industry Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 90 North America Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 91 North America Automation in Biopharma Industry Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 92 North America Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 93 North America Automation in Biopharma Industry Market Share Forecast by Automation Technology, 2024 & 2034 (%)
  • Figure 94 North America Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million, AGR %)
  • Figure 95 North America Automation in Biopharma Industry Market Share Forecast by Digitization Technology, 2024 & 2034 (%)
  • Figure 96 North America Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 97 North America Automation in Biopharma Industry Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 98 North America Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million, AGR %)
  • Figure 99 North America Automation in Biopharma Industry Market Share Forecast by Component, 2024 & 2034 (%)
  • Figure 100 U.S. Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Canada Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 102 Europe Automation in Biopharma Industry Market Attractiveness Index
  • Figure 103 Europe Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
  • Figure 104 Europe Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million)
  • Figure 105 Europe Automation in Biopharma Industry Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 106 Europe Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million)
  • Figure 107 Europe Automation in Biopharma Industry Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 108 Europe Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million)
  • Figure 109 Europe Automation in Biopharma Industry Market Share Forecast by Automation Technology, 2024 & 2034 (%)
  • Figure 110 Europe Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million)
  • Figure 111 Europe Automation in Biopharma Industry Market Share Forecast by Digitization Technology, 2024 & 2034 (%)
  • Figure 112 Europe Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million)
  • Figure 113 Europe Automation in Biopharma Industry Market Share Forecast by Application, 2024 & 2034(%)
  • Figure 114 Europe Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million)
  • Figure 115 Europe Automation in Biopharma Industry Market Share Forecast by Component, 2024 & 2034(%)
  • Figure 116 Germany Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 117 UK Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 118 France Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 119 Italy Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 120 Spain Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 121 Switzerland Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 122 Netherlands Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 123 Rest of Europe Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 124 Asia Pacific Automation in Biopharma Industry Market Attractiveness Index
  • Figure 125 Asia Pacific Automation in Biopharma Industry Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 126 Asia Pacific Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million)
  • Figure 127 Asia Pacific Automation in Biopharma Industry Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 128 Asia Pacific Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million)
  • Figure 129 Asia Pacific Automation in Biopharma Industry Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 130 Asia Pacific Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million)
  • Figure 131 Asia Pacific Automation in Biopharma Industry Market Share Forecast by Automation Technology, 2024 & 2034 (%)
  • Figure 132 Asia Pacific Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million)
  • Figure 133 Asia Pacific Automation in Biopharma Industry Market Share Forecast by Digitization Technology, 2024 & 2034 (%)
  • Figure 134 Asia Pacific Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million)
  • Figure 135 Asia Pacific Automation in Biopharma Industry Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 136 Asia Pacific Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million)
  • Figure 137 Asia Pacific Automation in Biopharma Industry Market Share Forecast by Component, 2024 & 2034 (%)
  • Figure 138 Japan Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 139 China Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 140 India Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 141 Australia Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 142 South Korea Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 143 South East Asia Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 144 Rest of Asia Pacific Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 145 Latin America Automation in Biopharma Industry Market Attractiveness Index
  • Figure 146 Latin America Automation in Biopharma Industry Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 147 Latin America Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million)
  • Figure 148 Latin America Automation in Biopharma Industry Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 149 Latin America Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million)
  • Figure 150 Latin America Automation in Biopharma Industry Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 151 Latin America Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million)
  • Figure 152 Latin America Automation in Biopharma Industry Market Share Forecast by Automation Technology, 2024 & 2034 (%)
  • Figure 153 Latin America Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million)
  • Figure 154 Latin America Automation in Biopharma Industry Market Share Forecast by Digitization Technology, 2024 & 2034 (%)
  • Figure 155 Latin America Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million)
  • Figure 156 Latin America Automation in Biopharma Industry Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 157 Latin America Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million)
  • Figure 158 Latin America Automation in Biopharma Industry Market Share Forecast by Component, 2024 & 2034 (%)
  • Figure 159 Brazil Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 160 Mexico Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 161 Argentina Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 162 Rest of Latin America Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 163 MEA Automation in Biopharma Industry Market Attractiveness Index
  • Figure 164 MEA Automation in Biopharma Industry Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 165 MEA Automation in Biopharma Industry Market Forecast by Country, 2024-2034 (US$ Million)
  • Figure 166 MEA Automation in Biopharma Industry Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 167 MEA Automation in Biopharma Industry Market Forecast by Technology, 2024-2034 (US$ Million)
  • Figure 168 MEA Automation in Biopharma Industry Market Share Forecast by Technology, 2024 & 2034 (%)
  • Figure 169 MEA Automation in Biopharma Industry Market Forecast by Automation Technology, 2024-2034 (US$ Million)
  • Figure 170 MEA Automation in Biopharma Industry Market Share Forecast by Automation Technology, 2024 & 2034 (%)
  • Figure 171 MEA Automation in Biopharma Industry Market Forecast by Digitization Technology, 2024-2034 (US$ Million)
  • Figure 172 MEA Automation in Biopharma Industry Market Share Forecast by Digitization Technology, 2024 & 2034 (%)
  • Figure 173 MEA Automation in Biopharma Industry Market Forecast by Application, 2024-2034 (US$ Million)
  • Figure 174 MEA Automation in Biopharma Industry Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 175 MEA Automation in Biopharma Industry Market Forecast by Component, 2024-2034 (US$ Million)
  • Figure 176 MEA Automation in Biopharma Industry Market Share Forecast by Component, 2024 & 2034 (%)
  • Figure 177 GCC Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 178 South Africa Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 179 Egypt Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 180 Rest of MEA Automation in Biopharma Industry Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 181 Revvity Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 182 Revvity Inc.: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 183 Revvity Inc.: Segment Market Shares, 2023
  • Figure 184 Revvity Inc.: Regional Market Shares, 2023
  • Figure 185 Siemens Healthineers AG: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 186 Siemens Healthineers AG: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 187 Siemens Healthineers AG: Segment Market Shares, 2023
  • Figure 188 Siemens Healthineers AG: Regional Market Shares, 2023
  • Figure 189 ABB: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 190 ABB: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 191 ABB: Segment Market Shares, 2023
  • Figure 192 ABB: Regional Market Shares, 2023
  • Figure 193 Rockwell Automation: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 194 Rockwell Automation : R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 195 Rockwell Automation: Segment Market Shares, 2023
  • Figure 196 Rockwell Automation: Regional Market Shares, 2023
  • Figure 197 Thermo Fisher Scientific Inc.: Net Revenue, 2019-2023 (US$ Million, AGR (%)
  • Figure 198 Thermo Fisher Scientific Inc.: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 199 Thermo Fisher Scientific Inc.: Segment Market Shares, 2023
  • Figure 200 Thermo Fisher Scientific Inc.: Regional Market Shares, 2023
  • Figure 201 Sartorius AG: Net Revenue, 2019-2023 (US$ Million, AGR (%)
  • Figure 202 Sartorius AG: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 203 Sartorius AG: Segment Market Shares, 2023
  • Figure 204 Sartorius AG: Regional Market Shares, 2023
  • Figure 205 Emerson Electric
目次
Product Code: PHA1326

The global Automation in Biopharma Industry market is projected to grow at a CAGR of 7% by 2034

The Automation in Biopharma Industry Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increased Machine Flexibility and Labour Shortages Driving Industry Growth

Pharmaceutical businesses expressed their desire to use automated solutions more frequently, with 75% stating as much. The primary cause of this, in addition to a labour shortage, is the shift towards injectable and more specialized drugs. Injectable, for instance, have expanded by about 100%, and until 2027, parenteral containers are anticipated to develop at a compound annual growth rate (CAGR) of 5.2%. Pharmaceutical production systems face hurdles from things such as pre-filled syringes and customised doses. So, in order to handle the greater diversity of formats generated in smaller batch sizes, manufacturers are searching for gear that can limit downtime.

Manufacturers were experiencing a shortage of both experienced and unskilled workers; nevertheless, as many producers are aware, conditions have deteriorated significantly in the past two years. In 2022, PMMI, the Packaging and Processing Technologies Association, published a white paper in which it stated that 33% of pharmaceutical businesses were having trouble staffing their operations. Automated technologies and robotics may be able to help pharmaceutical companies with their labour problem. The retirement of almost 80 million baby boomers and the arrival of only 40 million new workers into the labour force at the same time will result in a serious talent deficit over the next 30 years. In the biopharma industry alone, there are over 800,000 workers, but there are over 60,000 unfilled positions, indicating an 8% labour shortage.

What Questions Should You Ask Before Buying a Market Research Report?

How is the Automation in Biopharma Industry market evolving?

What is driving and restraining the Automation in Biopharma Industry market?

How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Automation in Biopharma Industry submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Automation in Biopharma Industry markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Automation in Biopharma Industry projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Automation in

Biopharma Industry projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Automation in Biopharma Industry market?

Where is the Automation in Biopharma Industry market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Automation in Biopharma Industry market today, and over the next 10 years:

Our 364-page report provides 138 tables, 226 charts, and graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Automation in Biopharma Industry market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), impact of rising Automation in Biopharma Industry prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Technology

Automation Technology

Digitization Technology

Automation Technology

Supervisory Control and Data Acquisition (SCADA)

Distributed Control Systems (DCS)

Programmable Logic Controllers (PLC)

Manufacturing Execution System (MES)

Human-machine Interface (HMI)

Advanced Process Control (APC)

Enterprise Resource Planning (ERP)

Laboratory Information Management System (LIMS)

Customer Relationship Management (CRM)

Corrective and Preventive Actions (CAPA)

Other Automation Technologies

Digitization Technology

Internet of things (IoT)

Artificial Intelligence (AI)

Digital Twin Technology

Augmented Reality (AR) and Virtual Reality (VR)

Predictive Analytics

Cloud Computing

Application

Clinical Phase

Drug Discovery Phase

Production Phase

Component

Automation Hardware

Automation Software

Services Project Phase

Services Operation Phase

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Switzerland

Netherlands

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

South East Asia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Egypt

Rest of MEA

The report also includes profiles and for some of the leading companies in the Automation in Biopharma Industry Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

ABB

Acieta

ADLINK Technology Inc.

AMETEK, Inc.

Baumuller

Emerson Electric Co.

Revvity Inc.

RheoSense Inc.

Rockwell Automation

Sartorius AG

Siemens Healthineers AG

TetraScience, Inc.

Thermo Fisher Scientific Inc.

Overall world revenue for automation in biopharma industry market, 2024 to 2034 in terms of value the market will surpass US$1,950 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Automation in Biopharma Industry Market, 2024 to 2034 report help you?

In summary, our 360+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Automation in Biopharma Industry Market, 2024 to 2034, with forecasts for technology, automation technology, digitization technology, application component, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 25 key national markets - See forecasts for the Automation in Biopharma Industry Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, South East Asia, Argentina, GCC, South Africa, and Egypt among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the automation in biopharma industry market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Automation in Biopharma Industry Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Automation in Biopharma Industry Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Industry Structure

    • 3.1.1 Technology is at the Forefront
    • 3.1.2 Automated Manufacturing
    • 3.1.3 Digital Twin in Pharmaceutical Manufacturing
      • 3.1.3.1 PAT Methods
    • 3.1.4 Process Modelling
    • 3.1.5 Advanced Process Control
    • 3.1.6 Regulatory Developments and Trends in Biopharma
  • 3.2 Overview of Automation in Biopharma Industry 4.0
    • 3.2.1 Types & Levels of Automation in Biopharma
    • 3.2.2 Biopharma, Digital Applications, and Industry 4.0
      • 3.2.2.1 Supply Chain
      • 3.2.2.2 Streamlining Marketing Efforts
      • 3.2.2.3 Acquiring Talent More Efficiently
    • 3.2.3 Manufacturing and Supply Chain
    • 3.2.4 Recent Trends & Developments

4 Market Overview

  • 4.1 Key Findings
  • 4.2 Market Dynamics
    • 4.2.1 Market Driving Factors
      • 4.2.1.1 Labour Shortages Comprising Both High- and Low-Skilled Workers
      • 4.2.1.2 Need for Increased Machine Flexibility
      • 4.2.1.3 Technological Advancements to Improve Product Safety
      • 4.2.1.4 Increased Adoption of Electronic Batch Records
    • 4.2.2 Market Restraining Factors
      • 4.2.2.1 Need for High Capital Investment Limits the Market Expansion
      • 4.2.2.2 Stringent Regulatory Norms to Challenge Market Growth
      • 4.2.2.3 Smaller Datasets
    • 4.2.3 Market Opportunities
      • 4.2.3.1 Working Smarter Using Digital Labour
      • 4.2.3.2 Robotics are Increasingly Regarded as Valuable to Operations
      • 4.2.3.3 Faster Hypothesis to Testing Cycles
  • 4.3 COVID-19 Impact Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Threat of Substitutes
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Bargaining Power of Buyers
    • 4.4.5 Competitive Rivalry
  • 4.5 SWOT Analysis
  • 4.6 PESTLE Analysis
    • 4.6.1 Political Factors Impacting Automation in Biopharma Industry Market
    • 4.6.2 Economic Factors Impacting Automation in Biopharma Industry Market
    • 4.6.3 Social Factors Impacting Automation in Biopharma Industry Market
    • 4.6.4 Technological Factors Impacting Automation in Biopharma Industry Market
    • 4.6.5 Legal Factors Impacting Automation in Biopharma Industry Market
    • 4.6.6 Environmental Factors Impacting Automation in Biopharma Industry Market
  • 4.7 Significance of Automation in the Pharmaceutical Industries
    • 4.7.1 Automated Filling, Inspection, and Packaging
    • 4.7.2 Making Personalised Medicines a Reality
    • 4.7.3 Involving Robotics in the Laboratory
    • 4.7.4 Continuous, Uninterrupted Manufacturing
    • 4.7.5 Automatic Control

5 Automation in Biopharma Industry Market Analysis by Technology

  • 5.1 Key Findings
  • 5.2 Technology Segment: Market Attractiveness Index
  • 5.3 Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
  • 5.4 Automation Technology
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Digitization Technology
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)

6 Automation in Biopharma Industry Market by Automation Technology

  • 6.1 Key Findings
  • 6.2 Automation Technology Segment: Market Attractiveness Index
  • 6.3 Automation in Biopharma Industry Market, by Automation Technology
  • 6.4 Supervisory Control and Data Acquisition (SCADA)
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Distributed Control Systems (DCS)
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Programmable Logic Controllers (PLC)
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Manufacturing Execution System (MES)
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)
  • 6.8 Human-machine Interface (HMI)
    • 6.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.8.2 Market Share by Region, 2024 & 2034 (%)
  • 6.9 Advanced Process Control (APC)
    • 6.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.9.2 Market Share by Region, 2024 & 2034 (%)
  • 6.10 Enterprise Resource Planning (ERP)
    • 6.10.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.10.2 Market Share by Region, 2024 & 2034 (%)
  • 6.11 Laboratory Information Management System (LIMS)
    • 6.11.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.11.2 Market Share by Region, 2024 & 2034 (%)
  • 6.12 Customer Relationship Management (CRM)
    • 6.12.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.12.2 Market Share by Region, 2024 & 2034 (%)
  • 6.13 Corrective and Preventive Actions (CAPA)
    • 6.13.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.13.2 Market Share by Region, 2024 & 2034 (%)
  • 6.14 Other Automation Technologies
    • 6.14.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.14.2 Market Share by Region, 2024 & 2034 (%)

7 Automation in Biopharma Industry Market by Digitization Technology

  • 7.1 Key Findings
  • 7.2 Digitization Technology Segment: Market Attractiveness Index
  • 7.3 Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
  • 7.4 Internet of Things (IoT)
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Artificial Intelligence (AI)
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Digital Twin Technology
    • 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)
  • 7.7 Augmented Reality (AR) and Virtual Reality (VR)
    • 7.7.1 Augmented Reality (AR) Technology
    • 7.7.2 Virtual Reality (VR) Technology
    • 7.7.3 Market Size by Region, 2024-2034 (US$ Million)
    • 7.7.4 Market Share by Region, 2024 & 2034 (%)
  • 7.8 Predictive Analytics
    • 7.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.8.2 Market Share by Region, 2024 & 2034 (%)
  • 7.9 Cloud Computing
    • 7.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.9.2 Market Share by Region, 2024 & 2034 (%)

8 Automation in Biopharma Industry Market by Application

  • 8.1 Key Findings
  • 8.2 Application Type Segment: Market Attractiveness Index
  • 8.3 Automation in Biopharma Industry Market by Application Forecast, 2024-2034
  • 8.4 Clinical Phase
    • 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.4.2 Market Share by Region, 2024 & 2034 (%)
  • 8.5 Drug Discovery Phase
    • 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.5.2 Market Share by Region, 2024 & 2034 (%)
  • 8.6 Production Phase
    • 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.6.2 Market Share by Region, 2024 & 2034 (%)

9 Automation in Biopharma Industry Market by Component

  • 9.1 Key Findings
  • 9.2 Component Segment: Market Attractiveness Index
  • 9.3 Automation in Biopharma Industry Market Size Estimation and Forecast by Component
  • 9.4 Automation Hardware
    • 9.4.1 Processing equipment
    • 9.4.2 Packaging Equipment
    • 9.4.3 Market Size by Region, 2024-2034 (US$ Million)
    • 9.4.4 Market Share by Region, 2024 & 2034 (%)
  • 9.5 Automation Software
    • 9.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.5.2 Market Share by Region, 2024 & 2034 (%)
  • 9.6 Services Project Phase
    • 9.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.6.2 Market Share by Region, 2024 & 2034 (%)
  • 9.7 Services Operation Phase
    • 9.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.7.2 Market Share by Region, 2024 & 2034 (%)

10 Automation in Biopharma Industry Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Automation in Biopharma Industry Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Automation in Biopharma Industry Market Attractiveness Index
  • 11.3 North America Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Country
  • 11.5 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
    • 11.5.1 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
    • 11.5.2 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
  • 11.6 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Application
  • 11.7 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Component
  • 11.8 U.S. Automation in Biopharma Industry Market Analysis
  • 11.9 Canada Automation in Biopharma Industry Market Analysis

12 Europe Automation in Biopharma Industry Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Automation in Biopharma Industry Market Attractiveness Index
  • 12.3 Europe Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Country
  • 12.5 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
    • 12.5.1 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
    • 12.5.2 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
  • 12.6 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Application
  • 12.7 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Component
  • 12.8 Germany Automation in Biopharma Industry Market Analysis
  • 12.9 UK Automation in Biopharma Industry Market Analysis
  • 12.10 France Automation in Biopharma Industry Market Analysis
  • 12.11 Italy Automation in Biopharma Industry Market Analysis
  • 12.12 Spain Automation in Biopharma Industry Market Analysis
  • 12.13 Switzerland Automation in Biopharma Industry Market Analysis
  • 12.14 Netherlands Automation in Biopharma Industry Market Analysis
  • 12.15 Rest of Europe Automation in Biopharma Industry Market Analysis

13 Asia Pacific Automation in Biopharma Industry Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia Pacific Automation in Biopharma Industry Market Attractiveness Index
  • 13.3 Asia Pacific Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 13.4 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Country
  • 13.5 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
    • 13.5.1 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
    • 13.5.2 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
  • 13.6 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Application
  • 13.7 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Component
  • 13.8 Japan Automation in Biopharma Industry Market Analysis
  • 13.9 China Automation in Biopharma Industry Market Analysis
  • 13.10 India Automation in Biopharma Industry Market Analysis
  • 13.11 Australia Automation in Biopharma Industry Market Analysis
  • 13.12 South Korea Automation in Biopharma Industry Market Analysis
  • 13.13 South East Asia Automation in Biopharma Industry Market Analysis
  • 13.14 Rest of Asia Pacific Automation in Biopharma Industry Market Analysis

14 Latin America Automation in Biopharma Industry Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Automation in Biopharma Industry Market Attractiveness Index
  • 14.3 Latin America Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 14.4 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Country
  • 14.5 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
    • 14.5.1 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
    • 14.5.2 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
  • 14.6 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Application
  • 14.7 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Component
  • 14.8 Brazil Automation in Biopharma Industry Market Analysis
  • 14.9 Mexico Automation in Biopharma Industry Market Analysis
  • 14.10 Argentina Automation in Biopharma Industry Market Analysis
  • 14.11 Rest of Latin America Automation in Biopharma Industry Market Analysis

15 MEA Automation in Biopharma Industry Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Automation in Biopharma Industry Market Attractiveness Index
  • 15.3 MEA Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 15.4 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Country
  • 15.5 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
    • 15.5.1 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
    • 15.5.2 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
  • 15.6 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Application
  • 15.7 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Component
  • 15.8 GCC Automation in Biopharma Industry Market Analysis
  • 15.9 South Africa Automation in Biopharma Industry Market Analysis
  • 15.10 Egypt Automation in Biopharma Industry Market Analysis
  • 15.11 Rest of MEA Automation in Biopharma Industry Market Analysis

16 Company Profiles

  • 16.1 Competitive Landscape, 2023
  • 16.2 Revvity Inc.
    • 16.2.1 Company Snapshot
    • 16.2.2 Company Overview
    • 16.2.3 Financial Analysis
      • 16.2.3.1 Net Revenue, 2019-2023
      • 16.2.3.2 R&D, 2019-2023
      • 16.2.3.3 Segment Market Shares, 2023
      • 16.2.3.4 Regional Market Shares, 2023
    • 16.2.4 Product Benchmarking
    • 16.2.5 Strategic Outlook
  • 16.3 Siemens Healthineers AG
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2019-2023
      • 16.3.3.2 R&D, 2019-2023
      • 16.3.3.3 Segment Market Shares, 2023
      • 16.3.3.4 Regional Market Shares, 2023
    • 16.3.4 Product Benchmarking
    • 16.3.5 Strategic Outlook
  • 16.4 ABB
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2019-2023
      • 16.4.3.2 R&D, 2019-2023
      • 16.4.3.3 Segment Market Shares, 2023
      • 16.4.3.4 Regional Market Shares, 2023
    • 16.4.4 Product Benchmarking
    • 16.4.5 Strategic Outlook
  • 16.5 Rockwell Automation
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Financial Analysis
      • 16.5.3.1 Net Revenue, 2019-2023
      • 16.5.3.2 R&D, 2019-2023
      • 16.5.3.3 Segment Market Shares, 2023
      • 16.5.3.4 Regional Market Shares, 2023
    • 16.5.4 Product Benchmarking
    • 16.5.5 Strategic Outlook
  • 16.6 Thermo Fisher Scientific Inc.
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Financial Analysis
      • 16.6.3.1 Net Revenue, 2018-2023
      • 16.6.3.2 R&D, 2019-2023
      • 16.6.3.3 Segment Market Shares, 2023
      • 16.6.3.4 Regional Market Shares, 2023
    • 16.6.4 Product Benchmarking
    • 16.6.5 Strategic Outlook
  • 16.7 Sartorius AG
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2019-2023
      • 16.7.3.2 R&D, 2019-2023
      • 16.7.3.3 Segment Market Shares, 2023
      • 16.7.3.4 Regional Market Shares, 2023
    • 16.7.4 Product Benchmarking
    • 16.7.5 Strategic Outlook
  • 16.8 RheoSense Inc.
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Product Benchmarking
    • 16.8.4 Strategic Outlook
  • 16.9 Emerson Electric Co.
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Financial Analysis
      • 16.9.3.1 Net Revenue, 2019-2023
      • 16.9.3.2 R&D, 2019-2023
      • 16.9.3.3 Segment Market Shares, 2023
      • 16.9.3.4 Regional Market Shares, 2023
    • 16.9.4 Product Benchmarking
    • 16.9.5 Strategic Outlook
  • 16.10 TetraScience, Inc.
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Product Benchmarking
    • 16.10.4 Strategic Outlook
  • 16.11 ADLINK Technology Inc.
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Financial Analysis
      • 16.11.3.1 Net Revenue, 2018-2022
      • 16.11.3.2 R&D, 2018-2022
      • 16.11.3.3 Segment Market Shares, 2022
      • 16.11.3.4 Regional Market Shares, 2022
    • 16.11.4 Product Benchmarking
    • 16.11.5 Strategic Outlook
  • 16.12 Acieta
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Product Benchmarking
    • 16.12.4 Strategic Outlook
  • 16.13 AMETEK, Inc.
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Financial Analysis
      • 16.13.3.1 Net Revenue, 2019-2023
      • 16.13.3.2 Segment Market Shares, 2022
      • 16.13.3.3 Regional Market Shares, 2022
    • 16.13.4 Product Benchmarking
    • 16.13.5 Strategic Outlook
  • 16.14 Baumuller
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Product Benchmarking
    • 16.14.4 Strategic Outlook

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from Visiongain
  • 17.2 Recommendations for Market Players